Global Recombinant Human Growth Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Recombinant Human Growth Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Recombinant human growth hormone is produced by gene recombinant Escherichia coli secretory expression technology, and it is completely consistent with human pituitary growth hormone in amino acid content, sequence and protein structure. In the field of pediatrics, replacement therapy with recombinant human growth hormone can significantly promote children's height growth and improve the growth and development of various organs and tissues throughout the body. At the same time, recombinant human growth hormone also plays an important role in the fields of reproduction, burns and anti-aging.
Recombinant Human Growth Hormone report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Human Growth Hormone market is projected to reach US$ 7400.2 million in 2029, increasing from US$ 4268 million in 2022, with the CAGR of 8.2% during the period of 2024 to 2029. Demand from Childhood Growth Hormone Deficiency and Chronic Renal Insufficiency are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Human Growth Hormone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Recombinant Human Growth Hormone key manufacturers include Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck Serono, F.Hoffmann-La Roche, Ispen, Sandoz International and Changchun High-Tech Industries, etc. Novo Nordisk, LG Chem, Pfizer are top 3 players and held % sales share in total in 2022.
Recombinant Human Growth Hormone can be divided into Powder Injection and Water Injection, etc. Powder Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Recombinant Human Growth Hormone is widely used in various fields, such as Childhood Growth Hormone Deficiency, Chronic Renal Insufficiency, HIV Infection-Associated Wasting Syndrome and Adult GHD Replacement Therapy, etc. Childhood Growth Hormone Deficiency provides greatest supports to the Recombinant Human Growth Hormone industry development. In 2022, global % sales of Recombinant Human Growth Hormone went into Childhood Growth Hormone Deficiency filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Human Growth Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novo Nordisk
LG Chem
Pfizer
Eli lilly
Merck Serono
F.Hoffmann-La Roche
Ispen
Sandoz International
Changchun High-Tech Industries
Shenzhen Kexing Pharmaceutical
Changchun GeneScience Pharmaceutical
Anhui Anke Biotechnology
Segment by Type
Powder Injection
Water Injection
Childhood Growth Hormone Deficiency
Chronic Renal Insufficiency
HIV Infection-Associated Wasting Syndrome
Adult GHD Replacement Therapy
Small For Gestational Age (SGA)
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Human Growth Hormone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Human Growth Hormone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Human Growth Hormone industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Human Growth Hormone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Human Growth Hormone introduction, etc. Recombinant Human Growth Hormone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Recombinant Human Growth Hormone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Recombinant Human Growth Hormone report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Human Growth Hormone market is projected to reach US$ 7400.2 million in 2029, increasing from US$ 4268 million in 2022, with the CAGR of 8.2% during the period of 2024 to 2029. Demand from Childhood Growth Hormone Deficiency and Chronic Renal Insufficiency are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Human Growth Hormone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Recombinant Human Growth Hormone key manufacturers include Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck Serono, F.Hoffmann-La Roche, Ispen, Sandoz International and Changchun High-Tech Industries, etc. Novo Nordisk, LG Chem, Pfizer are top 3 players and held % sales share in total in 2022.
Recombinant Human Growth Hormone can be divided into Powder Injection and Water Injection, etc. Powder Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Recombinant Human Growth Hormone is widely used in various fields, such as Childhood Growth Hormone Deficiency, Chronic Renal Insufficiency, HIV Infection-Associated Wasting Syndrome and Adult GHD Replacement Therapy, etc. Childhood Growth Hormone Deficiency provides greatest supports to the Recombinant Human Growth Hormone industry development. In 2022, global % sales of Recombinant Human Growth Hormone went into Childhood Growth Hormone Deficiency filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Human Growth Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novo Nordisk
LG Chem
Pfizer
Eli lilly
Merck Serono
F.Hoffmann-La Roche
Ispen
Sandoz International
Changchun High-Tech Industries
Shenzhen Kexing Pharmaceutical
Changchun GeneScience Pharmaceutical
Anhui Anke Biotechnology
Segment by Type
Powder Injection
Water Injection
Segment by Application
Childhood Growth Hormone Deficiency
Chronic Renal Insufficiency
HIV Infection-Associated Wasting Syndrome
Adult GHD Replacement Therapy
Small For Gestational Age (SGA)
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Human Growth Hormone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Human Growth Hormone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Human Growth Hormone industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Human Growth Hormone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Human Growth Hormone introduction, etc. Recombinant Human Growth Hormone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Recombinant Human Growth Hormone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices